The evaluation of pharmaceutical magnesium availability from unmodified release tablets

Journal Title: Annales Academiae Medicae Silesiensis - Year 2015, Vol 69, Issue

Abstract

INTRODUCTION. Magnesium is one of the macroelements required to maintain normal body homeostasis. During studies, a positive effect in the prevention of cardiovascular disease, postmenopausal osteoporosis and diabetes was found. Unfortunately a deficiency of this element in the daily diet was observed, so supplementation is recommended. The aim of the study was to determine the influence of the kind of magnesium compound on the availability of Mg2+ with a tablet with an unmodified release rate. MATERIALS AND METHODS. The following preparations were used: Biomagnezja 150, Citromag B6 and Biomag-nezja Plus (FZNP "Biochefa"). Examination of the release rate of the active substance was performed in a paddle appa-ratus at T = 37°C ± 0.5°C for 120 min., with a mixer at 50 revolutions/min. and using 0.1 mol/dm3 HCl (pH = 1.2). For analysis of the magnesium release, Statistica software with pharmaceutical extensions: Dissolution Profiles was used. RESULTS. Analysis of the tested products showed that the % of magnesium released increased in the following order: Biomagnezja Plus, Biomagnezja 150, Citromag B6 and was respectively 45%, 61% and 70 %. The release rate con-stant increased in the same order and it was respectively 0.0138 min-1, 0.0146 min-1, 0.018 min-1. CONCLUSIONS. The factors affecting the release of magnesium in vitro are the solubility of the compound, the pres-ence of an inorganic anion or an organic ligand and the stability of the compound. A higher solubility makes a higher percentage of release. The presence of an organic ligand (hydrogen citrate) determines a greater percentage of the released dose in comparison with the magnesium oxide thereof.

Authors and Affiliations

Aneta Ostróżka-Cieślik, Barbara Dolińska, Florian Ryszka

Keywords

Related Articles

Proces starzenia a czynność gruczołów wydzielania wewnętrznego

Starzenie społeczeństw staje się największym wyzwaniem medycznym XXI w. Organizm osób w podeszłym wieku wykazuje obniżoną umiejętność przystosowywania się do zmiennych warunków środowiska zewnętrznego i wewnętrznego. Sta...

Związane z wiekiem zmiany w układzie arginazy-NO-syntazy w grupie pacjentów z chorobą wieńcową współistniejącą z nadciśnieniem tętniczym

WSTĘP: Choroba wieńcowa jest najpowszechniejszą z chorób serca występujących na terenie Europy. Celem pracy było zbadanie intensywności metabolizmu L-argininy dwoma alternatywnymi sposobami (utleniającym przez NOS i nie...

Secondary school students’ knowledge on risk factors for cardiovascular diseases

introduction: Cardiovascular diseases constitute the most frequent cause of death, even exceeding cancer. The so--called risk factors, both modifiable and non-modifiable, play a significant role in their development. met...

Hippotherapy – an effective multi-profile treatment?

INTRODUCTION: Hippotherapy is a form of psychomotor therapy aided by a horse. Aim of the paper: The aim of the paper is to characterize hippotherapy as an effective method supporting rehabilitation of disabled people in...

1181G/C polymorphism of OPG gene and its association with osteoporosis in postmenopausal women

INTRODUCTION Osteoporosis is a systemic disease of the bone system, characterized by low bone mass and bone microarchitec-ture disturbances, increased bone brittleness and susceptibility to fracture. There is an essentia...

Download PDF file
  • EP ID EP380380
  • DOI 10.18794/aams/34318
  • Views 92
  • Downloads 0

How To Cite

Aneta Ostróżka-Cieślik, Barbara Dolińska, Florian Ryszka (2015). The evaluation of pharmaceutical magnesium availability from unmodified release tablets. Annales Academiae Medicae Silesiensis, 69(), 166-171. https://europub.co.uk./articles/-A-380380